Fixation of fingers II-V in the case of injury, inflammation (e.g. panaritium), degener-ative diseases and/or following surgery on the distal and/or middle phalanges and/or on the interphalangeal joints
The first patent on Chrisofix® technology was filed by K. Bolla MD., the founder of Chrisofix® Ltd. (Schaffhausen, Switzerland) at the end of 1995. The manufacturing of the Chrisofix® products was started in 1997 by Orkrisz Ltd. (Budapest). Since then, Chrisofix® Ltd. has been continuously extending its product range by developing new, patent-protected splinting technologies and products. The Chrisofix® technology is the newest fixation method characterized by combining the advantages of circular (e.g. plaster of Paris, thermoplastic materials) and segmental fixations (splints and ortheses). The use of Chrisofix® products makes the splinting quicker and more economical than the earlier developed limb fixation methods.